1:00 pm est.
Duration: 45 minutes

Join us for an engaging session introducing a new therapy now approved for adult and pediatric patients with spinal muscular atrophy (SMA). This broadcast will explore unmet needs across the SMA population, review key clinical evidence supporting this now-approved SMA therapy, and provide practical insights on integrating it into clinical practice. Through a dynamic panel discussion, experts will also share their perspectives on identifying appropriate patients for this new therapeutic option, followed by a live Q&A session.